These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17030707)

  • 1. Relative risk of progressive glaucomatous visual field loss in patients enrolled and not enrolled in a prospective longitudinal study.
    Henson DB; Shambhu S
    Arch Ophthalmol; 2006 Oct; 124(10):1405-8. PubMed ID: 17030707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of progressive change in automated visual fields in glaucoma.
    Smith SD; Katz J; Quigley HA
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1419-28. PubMed ID: 8641844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
    Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression.
    De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
    Arch Ophthalmol; 2009 Sep; 127(9):1129-34. PubMed ID: 19752421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual field progression outcomes in glaucoma subtypes.
    De Moraes CG; Liebmann JM; Liebmann CA; Susanna R; Tello C; Ritch R
    Acta Ophthalmol; 2013 May; 91(3):288-93. PubMed ID: 21974913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of focal lamina cribrosa defect on glaucomatous visual field progression.
    Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
    Ophthalmology; 2014 Aug; 121(8):1524-30. PubMed ID: 24697910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen Longitudinal Glaucoma Study.
    Wesselink C; Heeg GP; Jansonius NM
    Arch Ophthalmol; 2009 Mar; 127(3):270-4. PubMed ID: 19273789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of conventional and pattern discrimination perimetry in a prospective study of glaucoma patients.
    Ansari I; Chauhan BC; McCormick TA; LeBlanc RP
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4150-7. PubMed ID: 11095608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower corneal hysteresis is associated with more rapid glaucomatous visual field progression.
    De Moraes CV; Hill V; Tello C; Liebmann JM; Ritch R
    J Glaucoma; 2012; 21(4):209-13. PubMed ID: 21654511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of frequency-doubling technology for perimetrically normal eyes of open-angle glaucoma patients with unilateral field loss.
    Fan X; Wu LL; Ma ZZ; Xiao GG; Liu F
    Ophthalmology; 2010 Aug; 117(8):1530-7, 1537.e1-2. PubMed ID: 20466428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal structure-function relationships with scanning laser ophthalmoscopy and standard achromatic perimetry.
    Nassiri N; Nilforushan N; Coleman AL; Law SK; Caprioli J; Nouri-Mahdavi K
    Arch Ophthalmol; 2012 Jul; 130(7):826-32. PubMed ID: 22776919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucoma surgery decreases the rates of localized and global visual field progression.
    Folgar FA; de Moraes CG; Prata TS; Teng CC; Tello C; Ritch R; Liebmann JM
    Am J Ophthalmol; 2010 Feb; 149(2):258-264.e2. PubMed ID: 20103054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.
    Teng CC; De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 May; 117(5):909-15. PubMed ID: 20132988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of the optic nerve head for development or progression of glaucomatous visual field loss.
    Jonas JB; Martus P; Horn FK; Jünemann A; Korth M; Budde WM
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2613-8. PubMed ID: 15277484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for visual field progression in treated glaucoma.
    De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
    Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.